Compare TTK HEALTHCARE with Glenmark Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs GLENMARK PHARMA - Comparison Results

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE GLENMARK PHARMA TTK HEALTHCARE/
GLENMARK PHARMA
 
P/E (TTM) x 19.3 10.2 188.4% View Chart
P/BV x 1.5 1.5 105.5% View Chart
Dividend Yield % 1.0 0.7 145.4%  

Financials

 TTK HEALTHCARE   GLENMARK PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
GLENMARK PHARMA
Mar-19
TTK HEALTHCARE/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,215712 170.7%   
Low Rs610484 126.2%   
Sales per share (Unadj.) Rs444.4349.6 127.1%  
Earnings per share (Unadj.) Rs17.232.8 52.6%  
Cash flow per share (Unadj.) Rs27.644.3 62.3%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %0.50.3 163.7%  
Book value per share (Unadj.) Rs177.9198.6 89.6%  
Shares outstanding (eoy) m14.13282.17 5.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.11.7 120.1%   
Avg P/E ratio x52.918.2 290.2%  
P/CF ratio (eoy) x33.013.5 245.0%  
Price / Book Value ratio x5.13.0 170.5%  
Dividend payout %29.06.1 475.2%   
Avg Mkt Cap Rs m12,894168,625 7.6%   
No. of employees `0002.312.0 19.2%   
Total wages/salary Rs m1,30720,561 6.4%   
Avg. sales/employee Rs Th2,715.78,196.0 33.1%   
Avg. wages/employee Rs Th565.31,708.1 33.1%   
Avg. net profit/employee Rs Th105.4768.5 13.7%   
INCOME DATA
Net Sales Rs m6,27998,655 6.4%  
Other income Rs m782,081 3.7%   
Total revenues Rs m6,356100,736 6.3%   
Gross profit Rs m49615,858 3.1%  
Depreciation Rs m1473,259 4.5%   
Interest Rs m343,346 1.0%   
Profit before tax Rs m39311,335 3.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m01,672 0.0%   
Tax Rs m1493,756 4.0%   
Profit after tax Rs m2449,250 2.6%  
Gross profit margin %7.916.1 49.1%  
Effective tax rate %37.933.1 114.4%   
Net profit margin %3.99.4 41.4%  
BALANCE SHEET DATA
Current assets Rs m2,71766,968 4.1%   
Current liabilities Rs m1,57140,211 3.9%   
Net working cap to sales %18.327.1 67.3%  
Current ratio x1.71.7 103.9%  
Inventory Days Days3283 38.6%  
Debtors Days Days4781 57.5%  
Net fixed assets Rs m99133,322 3.0%   
Share capital Rs m141282 50.1%   
"Free" reserves Rs m2,37355,770 4.3%   
Net worth Rs m2,51456,052 4.5%   
Long term debt Rs m335,738 0.0%   
Total assets Rs m4,158132,888 3.1%  
Interest coverage x12.64.4 287.5%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x1.50.7 203.4%   
Return on assets %6.79.5 70.4%  
Return on equity %9.716.5 58.7%  
Return on capital %16.917.8 95.1%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22562,998 0.4%   
Fx outflow Rs m7122,859 0.3%   
Net fx Rs m15440,140 0.4%   
CASH FLOW
From Operations Rs m17313,242 1.3%  
From Investments Rs m97-6,990 -1.4%  
From Financial Activity Rs m-307-7,387 4.2%  
Net Cashflow Rs m-38-2,971 1.3%  

Share Holding

Indian Promoters % 65.4 48.3 135.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 6.9 53.6%  
FIIs % 5.2 34.4 15.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.5 245.7%  
Shareholders   12,723 56,727 22.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   J.B.CHEMICALS  SUVEN LIFESCIENCES  CIPLA  AJANTA PHARMA  ALEMBIC LTD  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

GLENMARK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 53.1% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, GLENMARK PHARMA has posted a net profit of Rs 1 bn (down 53.1% YoY). Sales on the other hand came in at Rs 23 bn (up 7.3% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Nov 11, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - LUPIN COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS